Repetitive transcranial magnetic (rTMS) is a safe, noninvasive treatment that involves placing a magnetic coil on a person’s head over an area of the brain called the dorsolateral prefrontal cortex (DLPFC). rTMS has been available as a treatment for depression in Canada since 2002, and although it has also been approved by Health Canada for the treatment of post-traumatic stress disorder (PTSD), there are only a limited number of studies that have looked at this.
The purpose of this study is to assess the effects of rTMS in civilian patients with a confirmed diagnosis of PTSD. This research study will determine whether low-frequency (1 Hertz [Hz]) or high-frequency (10 Hz) rTMS over the right DLPFC has an effect on symptoms of PTSD compared to sham rTMS treatment.
Visit ClinicalTrials.gov for more information.
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.